TSH-Controlled L-Thyroxine Therapy Reduces Cholesterol Levels and Clinical Symptoms in Subclinical Hypothyroidism: A Double Blind, Placebo-Controlled Trial (Basel Thyroid Study)
Open Access
- 1 October 2001
- journal article
- other
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 86 (10) , 4860-4866
Abstract
This study evaluated the effect of physiological, TSH-guided, l-thyroxine treatment on serum lipids and clinical symptoms in patients with subclinical hypothyroidism. Sixty-six women with proven subclinical hypothyroidism (TSH, 11.7 ± 0.8 mIU/liter) were randomly assigned to receive l-thyroxine or placebo for 48 wk. Individual l-thyroxine replacement (mean dose, 85.5 ± 4.3 μg/d) was performed based on blinded TSH monitoring, resulting in euthyroid TSH levels (3.1 ± 0.3 mIU/liter). Lipid concentrations and clinical scores were measured before and after treatment. Sixty-three of 66 patients completed the study. In the l-thyroxine group (n = 31) total cholesterol and low density lipoprotein cholesterol were significantly reduced [−0.24 mmol/liter, 3.8% (P = 0.015) and −0.33 mmol/liter, 8.2% (P = 0.004), respectively]. Low density lipoprotein cholesterol decrease was more pronounced in patients with TSH levels greater than 12 mIU/liter or elevated low density lipoprotein cholesterol levels at baseline. A significant decrease in apolipoprotein B-100 concentrations was observed (P = 0.037), whereas high density lipoprotein cholesterol, triglycerides, apolipoprotein AI, and lipoprotein(a) levels remained unchanged. Two clinical scores assessing symptoms and signs of hypothyroidism (Billewicz and Zulewski scores) improved significantly (P = 0.02). This is the first double blind study to show that physiological l-thyroxine replacement in patients with subclinical hypothyroidism has a beneficial effect on low density lipoprotein cholesterol levels and clinical symptoms of hypothyroidism. An important risk reduction of cardiovascular mortality of 9–31% can be estimated from the observed improvement in low density lipoprotein cholesterol.Keywords
This publication has 27 references indexed in Scilit:
- Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic diseaseEuropean Journal of Clinical Investigation, 2001
- American Thyroid Association Guidelines for Detection of Thyroid DysfunctionArchives of internal medicine (1960), 2000
- The Colorado Thyroid Disease Prevalence StudyArchives of internal medicine (1960), 2000
- Does treatment withl-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism?Journal of General Internal Medicine, 1996
- Effect of l-thyroxine therapy on lipoprotein fractions in overt and subclinical hypothyroidism, with special reference to lipoprotein(a)Metabolism, 1995
- Prevalence and Correction of Hypothyroidism in a Large Cohort of Patients Referred for DyslipidemiaArchives of internal medicine (1960), 1995
- Spectrum of subclinical and overt hypothyroidism: Effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissuesThe American Journal of Medicine, 1992
- The aging thyroid. Increased prevalence of elevated serum thyrotropin levels in the elderlyJAMA, 1979
- The systolic time intervals in thyroid dysfunctionAmerican Heart Journal, 1978
- SYMPTOMLESS AUTOIMMUNE THYROIDITIS IN CORONARY HEART-DISEASEThe Lancet, 1972